Original release date: February 8, 2022
Access to this course expires on: March 18, 2024 at 11:59 PM Pacific Time
For complimentary access to this item, please enter this promo code at check-out: TT2021
An overview of the pandemic response with regard to COVID-19 tests will be given along with lessons learned. There will be a focus on the innovation required by test developers and the FDA that yielded hundreds of authorized tests, each meeting distinct needs. Further, these innovations will be shown to be important for future advancements in tests that go beyond COVID-19.
This course is designed for general pathologists, practicing surgical pathologists, senior residents and pathologists with special interest in head and neck pathology.
Upon completion of this educational activity, learners will be able to:
- Understand the breadth and depth of COVID-19 tests that were developed and how they were utilized in the pandemic.
- Understand the lessons learned and how they can apply to any future pandemics.
- Understand the technology innovations utilized in the COVID-19 pandemic and how they advance a wide range of other testing opportunities.
Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Timothy T. Stenzel, MD, PhD
The following planners reported financial relationships:
Yuri Fedoriw: Consultant, Alexion Pharmaceuticals; Grant or Research Support, BioFluidica
Jason Hornick: Consultant, Eli Lilly, Epizyme, Aadi Bioscience
Liron Pantanowitz: Consultant, Hamamatsu; Advisory Board Member, Ibex
The following planners reported no relevant financial relationships: Zubair Baloch, Daniel Brat, Laura Collins, Sarah Dry, William Faquin, Karen Fritchie, Jennifer Gordetsky, Kristin Jensen, Melinda Lerwill, Anna Marie Mulligan, David Papke, Jr., Carlos Parra-Herran, Rajiv Patel, Deepa Patil, Charles Quick, Raja Seethala, Olga Weinberg, Ilan Weinreb, Maria Westerhoff, Rhonda Yantiss, Nicholas Zoumberos.
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.
Not A Member? Click Here to sign up and receive a discounted rate on all e-Learning courses.